Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2004-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1904850377034b0d03f1e25333c30ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90152c08792303cbb71ee28c78c8635d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e85d36fa5c16e25debe5d48c0f111a42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db319da0db89211554d2eef3406e90b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f61bb807400f4c8fc771f384fb5f703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809012cb820bf51b5cd5b5a5ea9217fc |
publicationDate |
2009-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NZ-547558-A |
titleOfInvention |
Compositions and methods for the treatment of tumor of hematopoietic origin |
abstract |
Provided is the use of an antibody that specifically binds a protein having at least 80% amino acid sequence identity to a specified polypeptide sequence or a corresponding nucleotide sequence in the manufacture of a medicament for inhibiting unwanted cell growth or treating cancer wherein the medicament is formulated for contacting said cell with an antibody that binds to said protein thereby causing an inhibition of growth of said cell, wherein said antibody is conjugated to a growth inhibitory agent or cytotoxic agent. |
priorityDate |
2003-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |